Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for QTc effects in mechanically ventilated ICU patients
ChiCTR2500103616Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in None comparing Propofol group with Dexmedetomidine group (2 arms). Primary endpoint: Incidence of QTc prolongation. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofol
Beyond the preview
Go deeper on ChiCTR2500103616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103616.